Northwell Health’s Constellation Gala raises more than $3M to support healthcare innovation in Manhattan

More than $3 million was raised at Northwell Health’s annual Constellation Gala, held virtually on November 9. The event celebrates philanthropic support as the driving force of innovations throughout Northwell Health that are transforming health care around the country.

Hosted by Colin Jost, co-head writer of “Saturday Night Live,” this year’s Constellation Gala featured special performances from the company of the Tony and Grammy Award-winning musical, “Dear Evan Hansen,” and the Northwell Health Nurse Choir. Attendees included New York City leaders from various industries and philanthropists and volunteer leaders who support Northwell’s Manhattan care sites.

Proceeds from the Constellation Gala will provide greater access to high-quality care by helping to advance innovative services and programs across Manhattan including at Lenox Hill Hospital; Manhattan Eye, Ear & Throat Hospital (MEETH); and Lenox Health Greenwich Village.

“The momentum and energy of Northwell’s presence in Manhattan is palpable,” said Michael Dowling, president and CEO of Northwell Health. “With more than 90 care facilities across the city, we are providing greater access to high-quality, convenient health care closer to the communities where people live.”

Serving Manhattan for more than 160 years, iconic Lenox Hill Hospital has been a cornerstone in the community. It offers world-class inpatient and surgical care at one of the most sophisticated hospitals in New York City, as well as seamless, convenient access to care at MEETH, Lenox Health Greenwich Village and nearby outpatient practices.

“The last two years through a pandemic have been so challenging for everyone, but Northwell came through stronger than ever and fulfilled its commitment to the community,” said Paul Guenther, chair of Northwell’s Western Regional Executive Council. “We never lost sight that it’s about making the lives of people better, and through the support of our donors, we can continue advancing our vision for quality care and innovation that makes a difference for our patients.”

Outpacing the Impossible campaign has raised more than $895 million

The event supported Northwell’s Outpacing the Impossible campaign, a $1 billion comprehensive fundraising effort to fuel innovation to advance health care and support Northwell’s promise to the people it serves. The campaign — which was publicly launched in October 2018 and to date, has raised more than $895 million — supports capital projects, improves hospitals and clinical programs, advances research and funds endowment for teaching and research initiatives.

Leading sponsors of the Constellation Gala included Ellen & Daniel M. Crown, Laura & Michael G. Fisch, Diane & Paul B. Guenther, Beth & Peter Hammack, Phyllis & William L. Mack, Iris & Michael Smith, Donald Zucker & Barbara Hrbek Zucker, Margaret M. Crotty & Rory Riggs and Tara & Roy J. Zuckerberg.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”